Status:

COMPLETED

Press Needle Acupoint Stimulation Combined With Breast Massage on the Initiation of Lactogenesis II

Lead Sponsor:

Qingdao Municipal Hospital

Conditions:

Lactation Induced

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

This RCT aimed to rigorously evaluate the combined effects of press needle acupuncture and breast massage on accelerating the onset of lactogenesis II, thereby optimizing breastfeeding outcomes and ma...

Detailed Description

This RCT aimed to rigorously evaluate the combined effects of press needle acupuncture and breast massage on accelerating the onset of lactogenesis II, thereby optimizing breastfeeding outcomes and ma...

Eligibility Criteria

Inclusion

  • Mothers ≥18 years old
  • Expecting their first live-born child via cesarean delivery
  • Having a singleton pregnancy
  • Intending to breastfeed with no major contraindications like hepatitis B, HIV, or other infectious diseases
  • Having newborns with Apgar scores above 8 at 1 and 5 minutes, robust sucking reflex, and no neonatal transfer required
  • Able to understand and respond to questions
  • Accessible for follow-up via telephone or WeChat

Exclusion

  • Mothers having previous breast surgeries like biopsies or augmentations
  • Having nipple inversions that complicate breastfeeding; (c) taking medications affecting lactation
  • Experiencing severe perinatal complications, such as serious pre-eclampsia or grade 3 or higher cardiac issues per NYHA standards
  • Having severe local skin damage at the acupoint and massage sites
  • Having newborns with critical conditions like cardiopulmonary insufficiency, galactosemia, or phenylketonuria

Key Trial Info

Start Date :

December 28 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 21 2024

Estimated Enrollment :

132 Patients enrolled

Trial Details

Trial ID

NCT06498882

Start Date

December 28 2023

End Date

June 21 2024

Last Update

July 12 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Qingdao Municipal Hospital

Qingdao, Shandong, China, 266000